Endonovo Therapeutics Inc. will conduct a reverse stock split of its shares at a 1-for-1,000 ratio.
The split will cut the Woodland Hills, Calif.-based medical device company's estimated 1,005,306,406 outstanding shares of common stock down to approximately 100,530. Following the reverse stock split, fractional shares will round up to a full share for the stockholders who hold them.
The company's exchange agent, Equity Stock Transfer, will guide shareholders on how to exchange existing share certificates for new ones post-split.
Endonovo will continue to trade on the OTCQB under its existing ticker of ENDVD after the reverse stock split.